DFT Based QSAR/QSPR Models in the Development of Novel Anti-tuberculosis Drugs Targeting Mycobacterium tuberculosis

E-ISSN： 1873-4286|20|27|4455-4473

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.27, 2014-08, pp. : 4455-4473

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Anti-Tuberculosis Drugs with Novel Mechanisms of Action

Current Medicinal Chemistry, Vol. 15, Iss. 19, 2008-01 ,pp. : 1956-1967

Bentham Science Publishers

Access to resources Recommend Favorite

New Anti-Tuberculosis Drugs in Clinical Development: An Overview

Current Bioactive Compounds, Vol. 5, Iss. 2, 2009-06 ,pp. : 137-154

Bentham Science Publishers

Access to resources Recommend Favorite

Predictive In Vitro Models of the Sterilizing Activity of Anti-Tuberculosis Drugs

Current Pharmaceutical Design, Vol. 10, Iss. 26, 2004-10 ,pp. : 3285-3295

Bentham Science Publishers

Access to resources Recommend Favorite

Nitrofurans as Novel Anti-tuberculosis Agents: Identification, Development and Evaluation

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 5, 2007-03 ,pp. : 509-526

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Tuberculosis

Current Bioactive Compounds, Vol. 2, Iss. 1, 2006-03 ,pp. : 105-105

Bentham Science Publishers

Access to resources Recommend Favorite